Cardinal Health, Inc. (NYSE:CAH) has been experiencing some noteworthy traction in the financial market. The company's shares have been seeing significant acquisition by asset management and investment firms like
Wakefield Asset Management LLLP,
Strategic Financial Concepts LLC, and
Denali Advisors LLC. In the corporate actions corner, the
Board of Directors has approved a
quarterly dividend while
institutional investors maintain a strong backing with 88% ownership. Cardinal Health has consistently beaten its
Q4 sales targets and successfully raised its Fiscal Year 2025 outlook, indicating a strong financial performance. Certain acquisitions signal strategic expansion endeavors for the company. Notably, purchases of two health tech firms -
Integrated Oncology Network and
GI Alliance expand the company's gastroenterology and diabetic businesses, fortifying its position in the healthcare sector. Set to enhance its logistical capabilities, Cardinal Health is opening new
distribution centers in Texas and South Carolina.
Jim Cramer and multiple analysts have given Cardinal Health a favorable rating, with the stock reaching an all-time high amid strong earnings and promising growth.
Cardinal Health CAH News Analytics from Wed, 14 Aug 2024 07:00:00 GMT to Sat, 01 Mar 2025 11:20:48 GMT -
Rating 8
- Innovation 2
- Rumor -2
